SCHEMBL3854593

SCHEMBL3854593

OCc1ccccc1-c1ccccc1Br

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.50
TAAR1 Q96RJ0 3/20 0.45
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
APOBEC3G Q9HC16 1/20 0.41
BAZ2B Q9UIF8 2/20 0.40
BAZ2A Q9UIF9 2/20 0.40
BRD4 O60885 1/20 0.40
BRD9 Q9H8M2 1/20 0.40
IDO1 P14902 2/20 0.39
KCNN4 O15554 1/20 0.37
GRM2 Q14416 1/20 0.37
PDK2 Q15119 2/20 0.36
DPP4 P27487 2/20 0.36
GPR52 Q9Y2T5 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1221964 0.85 PDCD1 (0.54) PDCD1CD274APOBEC3GBAZ2BBAZ2A
SCHEMBL28483705 0.81 ALDH1A1 (0.45) ALDH1A1MAPK1TAAR1PDCD1CD274
SCHEMBL110893 0.80
SCHEMBL10535771 0.79 PDCD1 (0.45) ALDH1A1PDCD1CD274APOBEC3GBAZ2B
SCHEMBL17051207 0.79 PDCD1 (0.45) PDCD1CD274APOBEC3GBAZ2BBAZ2A
Lithium Ion SCHEMBL10534528 0.78 PDCD1 (0.48) PDCD1CD274APOBEC3GBAZ2BBAZ2A
SCHEMBL8067284 0.77 GABRA1 (0.50) ALDH1A1MAPK1TAAR1IDO1
SCHEMBL31295703 0.77 ALDH1A1 (0.67) ALDH1A1MAPK1TAAR1APOBEC3GIDO1
SCHEMBL358976 0.77 ALDH1A1 (0.67) ALDH1A1MAPK1TAAR1APOBEC3GIDO1
SCHEMBL1928303 0.76 IDO1 (0.47) ALDH1A1MAPK1TAAR1APOBEC3GIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104016971-B Antiviral compound PHARMASSET INC. (US) 2016-05-25 CN disclosed
US-7592487-B2 Chiral tertiary aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2009-09-22 US disclosed
US-7572927-B2 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound FUJIFILM CORPORATION (JP) 2009-08-11 US disclosed
US-20080194816-A1 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound FUJIFILM CORPORATION (JP) 2008-08-14 US disclosed
EP-1727783-A4 CHIRAL TERTIARY AMINOALKYLNAPHTHOLS UNIV HONG KONG POLYTECHNIC (CN) 2008-03-19 EP disclosed
US-20080045757-A1 Chiral Tertiary Aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2008-02-21 US disclosed
EP-1727783-A1 CHIRAL TERTIARY AMINOALKYLNAPHTHOLS The Hong Kong Polytechnic University (CN) 2006-12-06 EP disclosed
WO-2005087707-A1 CHIRAL TERTIARY AMINOALKYLNAPHTHOLS THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194816-A1 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound DDT, OXER1, OSTC ALDH1A1 1259/4885MAPK1 2478/4885TAAR1 3009/4885
US-20080045757-A1 Chiral Tertiary Aminoalkylnaphthols ALDH7A1, ADH5, ALDH1A1 ALDH1A1 3/4885MAPK1 3690/4885TAAR1 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.